Fresenius Medical Care Holdings, Inc. Naturalyte Liquid Acid concentrate bottles, Product Code 08-1251-1 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Naturalyte Liquid Acid concentrate bottles, Product Code 08-1251-1 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.
Brand
Fresenius Medical Care Holdings, Inc.
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Lot Numbers: 20LXAC063 20NXAC008 Additional Affected lots as of 3/17/21: 20NXAC005 20LXAC098 20NXAC039 20NXAC008 20LXAC063
Fresenius Medical Care Holdings, Inc. is recalling Naturalyte Liquid Acid concentrate bottles, Product Code 08-1251-1 - Product Usage: used in conjunct due to The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescri. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.
Recommended Action
Per FDA guidance
An Urgent Medical Device Recall notification letter dated 11/23/20 was sent to customers. Fresenius Medical Care Renal Therapies Group, LLC (FMCRTG) previously issued Urgent Medical Device Alerts on November 7, 2020 and November 14, 2020 alerting you to issues pertaining to the sodium level in the Naturalyte Liquid Acid concentrate and Citrasate Liquid Acid concentrate products impacting 105 lots, manufactured at the Oregon, Ohio facility between September 9, 2020 and October 29, 2020. After further testing, FMCRTG is now voluntarily recalling 28 of the 105 lots for one or both of the following reasons: " The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. " Calcium concentration is below manufacturing specification. The 28 lots were released for distribution between September 30, 2020 and November 20, 2020. Please check your stock and discontinue use and/or distribution of the products. If you have any listed lot numbers, place the product in a secure, segregated area. Please contact Stericycle at 1-866-912-9552 for instructions on how to return the product and receive credit This is EVENT# 5857. o If returning single bottles, please place affected product in a box for pick up. o In order to receive credit for your impacted product, you must call the Stericycle phone number above and provide quantities for return. Additional Information: If urgent replacement of product is needed, please call FMCRTG Customer Service at 1-800-323-5188. Otherwise, please add any additional product request to your next scheduled delivery. We apologize for any inconvenience. Please complete and return the enclosed Reply Form at your earliest convenience and contact our Customer Services team at 1-800-323-5188 with any additional questions. Please contact our Medical Information team at 1-855-616-2309 to discuss any medical or scie
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026